Näytä suppeat kuvailutiedot

Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy

Auranen Mari; Lehtonen Marko; Koskivuori Johanna; Zetterberg Henrik; Harjuhaahto Sandra; Jokela Manu; Saukkonen Anna Maija; Palu Edourad; Kvist Jouni; Järvilehto Julius; Ylikallio Emil; Tyynismaa Henna

dc.contributor.authorAuranen Mari
dc.contributor.authorLehtonen Marko
dc.contributor.authorKoskivuori Johanna
dc.contributor.authorZetterberg Henrik
dc.contributor.authorHarjuhaahto Sandra
dc.contributor.authorJokela Manu
dc.contributor.authorSaukkonen Anna Maija
dc.contributor.authorPalu Edourad
dc.contributor.authorKvist Jouni
dc.contributor.authorJärvilehto Julius
dc.contributor.authorYlikallio Emil
dc.contributor.authorTyynismaa Henna
dc.date.accessioned2022-10-27T11:52:20Z
dc.date.available2022-10-27T11:52:20Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/155537
dc.description.abstract<p><strong>Objective: </strong>To characterize serum biomarkers in mitochondrial CHCHD10-linked spinal muscular atrophy Jokela (SMAJ) type for disease monitoring and for the understanding of pathogenic mechanisms.</p><p><strong>Methods: </strong>We collected serum samples from a cohort of 49 patients with SMAJ, all carriers of the heterozygous c.197G>T p.G66V variant in <em>CHCHD10</em>. As controls, we used age- and sex-matched serum samples obtained from Helsinki Biobank. Creatine kinase and creatinine were measured by standard methods. Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) were measured with single molecule array (Simoa), fibroblast growth factor 21 (FGF-21), and growth differentiation factor 15 (GDF-15) with an enzyme-linked immunosorbent assay. For non-targeted plasma metabolite profiling, samples were analyzed with liquid chromatography high-resolution mass spectrometry. Disease severity was evaluated retrospectively by calculating a symptom-based score.</p><p><strong>Results: </strong>Axon degeneration marker, NfL, was unexpectedly not altered in the serum of patients with SMAJ, whereas astrocytic activation marker, GFAP, was slightly decreased. Creatine kinase was elevated in most patients, particularly men. We identified six metabolites that were significantly altered in serum of patients with SMAJ in comparison to controls: increased creatine and pyruvate, and decreased creatinine, taurine, N-acetyl-carnosine, and succinate. Creatine correlated with disease severity. Altered pyruvate and succinate indicated a metabolic response to mitochondrial dysfunction; however, lactate or mitochondrial myopathy markers FGF-21 or GDF-15 was not changed.</p><p><strong>Conclusions: </strong>Biomarkers of muscle mass and damage are altered in SMAJ serum, indicating a role for skeletal muscle in disease pathogenesis in addition to neurogenic damage. Despite the minimal mitochondrial pathology in skeletal muscle, signs of a metabolic shift can be detected.</p>
dc.language.isoen
dc.publisherFRONTIERS MEDIA SA
dc.titleSerum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy
dc.identifier.urlhttps://doi.org/10.3389/fneur.2022.793937
dc.identifier.urnURN:NBN:fi-fe2022081153697
dc.relation.volume13
dc.contributor.organizationfi=kliinisen laitoksen yhteiset|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, vsshp|
dc.contributor.organization-code2607300
dc.converis.publication-id174884377
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/174884377
dc.identifier.jour-issn1664-2295
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorJokela, Manu
dc.okm.discipline3124 Neurology and psychiatryen_GB
dc.okm.discipline3124 Neurologia ja psykiatriafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumber793937
dc.relation.doi10.3389/fneur.2022.793937
dc.relation.ispartofjournalFrontiers in Neurology
dc.year.issued2022


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot